X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AMAR REMEDIES with THE PROCTER & GAMBLE CO. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs P&G (US) - Comparison Results

P&G (US)
   Change

Procter & Gamble Company (P&G) is an American multinational consumer goods company headquartered in the United States. The company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AMAR REMEDIES   P&G
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
P&G
Jun-14
AMAR REMEDIES/
P&G
5-Yr Chart
Click to enlarge
High Rs1645,846-   
Low Rs865,014-   
Sales per share (Unadj.) Rs261.62,059.0-  
Earnings per share (Unadj.) Rs17.4288.6-  
Cash flow per share (Unadj.) Rs22.3366.5-  
Dividends per share (Unadj.) Rs0166.89-  
Dividend yield (eoy) %03.1 0.0%  
Book value per share (Unadj.) Rs100.71,715.7-  
Shares outstanding (eoy) m26.162,748.03-   
Bonus/Rights/Conversions -BB, ESOP-  
Price / Sales ratio x0.52.6 18.1%   
Avg P/E ratio x7.218.8 38.2%  
P/CF ratio (eoy) x5.614.8 37.9%  
Price / Book Value ratio x1.23.2 39.2%  
Dividend payout %057.8 0.0%   
Avg Mkt Cap Rs m3,27014,922,314 0.0%   
No. of employees `000NA118.0 0.0%   
Total wages/salary Rs m1630-   
Avg. sales/employee Rs ThNM47,950.7-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM6,721.4-  
INCOME DATA
Net Sales Rs m6,8445,658,183 0.1%  
Other income Rs m2120,845 0.1%   
Total revenues Rs m6,8655,679,028 0.1%   
Gross profit Rs m1,1311,260,697 0.1%  
Depreciation Rs m128213,965 0.1%   
Interest Rs m39848,297 0.8%   
Profit before tax Rs m6261,019,280 0.1%   
Minority Interest Rs m0-9,673 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121216,485 0.1%   
Profit after tax Rs m455793,121 0.1%  
Gross profit margin %16.522.3 74.2%  
Effective tax rate %19.321.2 91.0%   
Net profit margin %6.614.0 47.4%  
BALANCE SHEET DATA
Current assets Rs m4,9042,153,750 0.2%   
Current liabilities Rs m3,5812,297,415 0.2%   
Net working cap to sales %19.3-2.5 -761.3%  
Current ratio x1.40.9 146.1%  
Inventory Days Days12430 418.4%  
Debtors Days Days10028 356.9%  
Net fixed assets Rs m1,6891,519,348 0.1%   
Share capital Rs m262348,774 0.1%   
"Free" reserves Rs m2,3580-   
Net worth Rs m2,6354,714,858 0.1%   
Long term debt Rs m5071,349,525 0.0%   
Total assets Rs m6,8629,753,013 0.1%  
Interest coverage x2.622.1 11.6%   
Debt to equity ratio x0.20.3 67.2%  
Sales to assets ratio x1.00.6 171.9%   
Return on assets %12.48.6 144.1%  
Return on equity %17.316.8 102.7%  
Return on capital %31.017.4 177.7%  
Exports to sales %4.00-   
Imports to sales %00-   
Net fx Rs m2710-   
CASH FLOW
From Operations Rs m-313950,819 -0.0%  
From Investments Rs m-489-279,769 0.2%  
From Financial Activity Rs m769-495,845 -0.2%  
Net Cashflow Rs m-33175,205 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for P&G (US) is United States Dollars. All data has been converted at 68.12 Rs / USD

Compare AMAR REMEDIES With: UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  

Compare AMAR REMEDIES With: PIDILITE INDUSTRIES  GODREJ CONSUMER  BAJAJ CORP  P&G HYGIENE  COLGATE  



Today's Market

Sensex up 200 Points; Realty Stocks Gain(12:30 pm)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and are presently trading above the dotted line.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS